• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短乳杆菌(CD2)对牙周病的抗炎作用

Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease.

作者信息

Riccia D N Della, Bizzini F, Perilli M G, Polimeni A, Trinchieri V, Amicosante G, Cifone M G

机构信息

Department of Experimental Medicine, University of L'Aquila, L'Aquila, Italy.

出版信息

Oral Dis. 2007 Jul;13(4):376-85. doi: 10.1111/j.1601-0825.2006.01291.x.

DOI:10.1111/j.1601-0825.2006.01291.x
PMID:17577323
Abstract

OBJECTIVES

To analyze the anti-inflammatory effects of Lactobacillus brevis extracts on periodontitis patients and to investigate the involved mechanisms in vitro on activated macrophages.

METHODS

Eight healthy subjects and 21 patients with chronic periodontitis were enrolled to analyze the effect of L. brevis-containing lozenges on periodontitis-associated symptoms and signs. Before and after the treatment, the patients received a complete periodontal examination. Saliva samples, collected before and after treatment, were analyzed for metalloproteinase and nitric oxide synthase (NOS) activity, immunoglobulin-A (IgA), prostaglandin E(2) (PGE(2)) and gamma-interferon (IFN-gamma) levels. Arginine deiminase (AD) and NOS activities were determined through a radiometric assay. Metalloproteinases were assayed by zymogram and Western blotting, whereas IgA, PGE(2) and IFN-gamma were assayed by enzyme-linked imunosorbent assay tests.

RESULTS

The treatment led to the total disappearance or amelioration of all analyzed clinical parameters in all patients. This was paralleled to a significant decrease of nitrite/nitrate, PGE(2), matrix metalloproteinase, and IFN-gamma levels in saliva samples.

CONCLUSION

Our results suggest that the anti-inflammatory effects of L. brevis could be attributed to the presence of AD which prevented nitric oxide generation. Our findings give further insights into the knowledge of the molecular basis of periodontitis and have a potential clinical significance, giving the experimental ground for a new innovative, simple and efficacious therapeutical approach of periodontal disease.

摘要

目的

分析短双歧杆菌提取物对牙周炎患者的抗炎作用,并在体外研究其对活化巨噬细胞的作用机制。

方法

招募8名健康受试者和21名慢性牙周炎患者,分析含短双歧杆菌含片对牙周炎相关症状和体征的影响。治疗前后,患者接受全面的牙周检查。对治疗前后采集的唾液样本进行分析,检测金属蛋白酶和一氧化氮合酶(NOS)活性、免疫球蛋白A(IgA)、前列腺素E2(PGE2)和γ干扰素(IFN-γ)水平。通过放射测定法测定精氨酸脱亚氨酶(AD)和NOS活性。通过酶谱法和蛋白质印迹法检测金属蛋白酶,而通过酶联免疫吸附测定法检测IgA、PGE2和IFN-γ。

结果

治疗使所有患者所有分析的临床参数完全消失或改善。这与唾液样本中亚硝酸盐/硝酸盐、PGE2、基质金属蛋白酶和IFN-γ水平的显著降低相平行。

结论

我们的结果表明,短双歧杆菌的抗炎作用可能归因于AD的存在,其可阻止一氧化氮的产生。我们的研究结果为牙周炎分子基础的认识提供了进一步的见解,具有潜在的临床意义,为牙周疾病一种新的创新、简单且有效的治疗方法提供了实验依据。

相似文献

1
Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease.短乳杆菌(CD2)对牙周病的抗炎作用
Oral Dis. 2007 Jul;13(4):376-85. doi: 10.1111/j.1601-0825.2006.01291.x.
2
Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss.用益生菌短乳杆菌CD2进行局部治疗可抑制实验性牙周炎症和骨质流失。
J Periodontal Res. 2014 Dec;49(6):785-91. doi: 10.1111/jre.12164. Epub 2014 Feb 1.
3
Modulation of the host response by probiotic Lactobacillus brevis CD2 in experimental gingivitis.短乳杆菌CD2对实验性牙龈炎宿主反应的调节作用
Oral Dis. 2015 Sep;21(6):705-12. doi: 10.1111/odi.12332. Epub 2015 Apr 20.
4
Probiotic strains of Lactobacillus brevis and Lactobacillus plantarum as adjunct to non-surgical periodontal therapy: 3-month results of a randomized controlled clinical trial.短双歧杆菌和植物乳杆菌益生菌株作为非手术牙周治疗的辅助手段:一项随机对照临床试验的 3 个月结果。
Clin Oral Investig. 2021 Mar;25(3):1411-1422. doi: 10.1007/s00784-020-03449-4. Epub 2020 Jul 14.
5
Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB.土木香内酯,一种来自大花旋覆花的倍半萜内酯,通过使核因子κB失活来抑制RAW 264.7巨噬细胞中诱导型一氧化氮合酶和环氧化酶-2的表达。
Br J Pharmacol. 2001 Jun;133(4):503-12. doi: 10.1038/sj.bjp.0704099.
6
Evaluation of salivary and serum methylated arginine metabolites and nitric oxide synthase in advanced periodontitis patients.晚期牙周炎患者唾液和血清中甲基化精氨酸代谢产物及一氧化氮合酶的评估
Clin Oral Investig. 2022 Jul;26(7):5061-5070. doi: 10.1007/s00784-022-04479-w. Epub 2022 Apr 14.
7
Effect of periodontal treatment on the protein composition of whole and parotid saliva.牙周治疗对全唾液和腮腺唾液蛋白质组成的影响。
J Periodontol. 1996 Mar;67(3):205-12. doi: 10.1902/jop.1996.67.3.205.
8
Salivary IL-1β and PGE2 as biomarkers of periodontal status, before and after periodontal treatment.唾液中 IL-1β 和 PGE2 作为牙周状况的生物标志物,在牙周治疗前后。
J Clin Periodontol. 2013 Dec;40(12):1112-7. doi: 10.1111/jcpe.12164. Epub 2013 Oct 1.
9
Use of a fluorogenic septapeptide matrix metalloproteinase assay to assess responses to periodontal treatment.使用荧光七肽基质金属蛋白酶检测法评估牙周治疗反应。
J Periodontol. 2000 May;71(5):690-700. doi: 10.1902/jop.2000.71.5.690.
10
Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.短小乳杆菌 CD2 含片可减少头颈部癌症患者放化疗引起的黏膜炎:一项随机、双盲、安慰剂对照研究。
Eur J Cancer. 2012 Apr;48(6):875-81. doi: 10.1016/j.ejca.2011.06.010. Epub 2011 Jul 6.

引用本文的文献

1
Clinical and microbiological effectiveness of limosilactobacillus reuteri in supportive periodontal therapy: randomized clinical trial.罗伊氏乳杆菌在支持性牙周治疗中的临床及微生物学疗效:随机临床试验
Clin Oral Investig. 2025 Aug 26;29(9):422. doi: 10.1007/s00784-025-06508-w.
2
Clinical and cost-effectiveness of synbiotics versus antibiotics and analgesics in post-tooth extraction socket healing: A randomized controlled trial.合生元与抗生素及镇痛药在拔牙创愈合中的临床疗效及成本效益:一项随机对照试验
Bioinformation. 2025 May 31;21(5):1719-1723. doi: 10.6026/973206300211719. eCollection 2025.
3
In Vitro, Ex Vivo, and In Vivo Evidence of Nitrate-Reducing Activity in CD2: A Potential Tool for Oral and Systemic Health Applications.
CD2中硝酸盐还原活性的体外、离体和体内证据:口腔及全身健康应用的潜在工具
Foods. 2025 Apr 26;14(9):1512. doi: 10.3390/foods14091512.
4
Levilactobacillus brevis CD2 as a multifaceted probiotic to preserve oral health: results of a double-blind, randomized, placebo-controlled trial in healthy adults.短双歧杆菌CD2作为维护口腔健康的多面益生菌:一项针对健康成年人的双盲、随机、安慰剂对照试验的结果
J Transl Med. 2025 Jan 28;23(1):128. doi: 10.1186/s12967-024-06000-1.
5
Small cyclic dipeptide produced by with anti-biofilm properties against biofilm.由……产生的具有抗生物膜特性的小型环二肽,针对……生物膜。 (原文表述似乎不完整,存在信息缺失情况)
Biofilm. 2024 Nov 6;8:100237. doi: 10.1016/j.bioflm.2024.100237. eCollection 2024 Dec.
6
Probiotics in the management of radiation-induced oral mucositis.益生菌在放射性口腔黏膜炎管理中的应用。
Front Cell Infect Microbiol. 2024 Sep 18;14:1477143. doi: 10.3389/fcimb.2024.1477143. eCollection 2024.
7
Preventive effect of probiotics on oral mucositis induced by anticancer therapy: a systematic review and meta-analysis of randomized controlled trials.益生菌预防抗癌治疗引起的口腔黏膜炎的效果:一项随机对照试验的系统评价和荟萃分析。
BMC Oral Health. 2024 Sep 29;24(1):1159. doi: 10.1186/s12903-024-04955-7.
8
miR-708-3p targetedly regulates LSD1 to promote osteoblast differentiation of hPDLSCs in periodontitis.微小RNA-708-3p靶向调控赖氨酸特异性去甲基化酶1以促进牙周炎中人类牙周膜干细胞向成骨细胞分化
Odontology. 2025 Jan;113(1):222-230. doi: 10.1007/s10266-024-00963-9. Epub 2024 Jul 3.
9
Microbiota based personalized nutrition improves hyperglycaemia and hypertension parameters and reduces inflammation: a prospective, open label, controlled, randomized, comparative, proof of concept study.基于微生物组的个性化营养可改善高血糖和高血压参数并降低炎症:一项前瞻性、开放标签、对照、随机、比较、概念验证研究。
PeerJ. 2024 Jun 26;12:e17583. doi: 10.7717/peerj.17583. eCollection 2024.
10
Efficacy of the Probiotic in Counteracting the Demineralizing Process of the Tooth Enamel Surface: Results from an In Vitro Study.益生菌在对抗牙釉质表面脱矿过程中的功效:一项体外研究的结果。
Biomolecules. 2024 May 20;14(5):605. doi: 10.3390/biom14050605.